ARTICLE | Company News
University of Utah, LSK BioPharma deal
September 21, 2015 7:00 AM UTC
The Huntsman Cancer Institute at the university granted LSK exclusive, worldwide rights to develop and commercialize HCI-1401, a preclinical small molecule that irreversibly inhibits Bruton’s tyrosin...